NORVARTIS PHARMACEUTICAL CORPORATION SANDOZ DIVISION | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for NORVARTIS PHARMACEUTICAL CORPORATION SANDOZ DIVISION

Sort by

Viewing results 1‒25 of 193

News updates from January 31: Federal Reserve holds interest rates, EU commits €21bn in Ukraine military aid
Novartis boosts sales by 10% as heart and arthritis medicines help beat guidance
...The $244bn Swiss group posted more than $45bn in sales, with core operating income earnings coming to $16.3bn, in a year in which it completed a spin-off of its consumer health division Sandoz....
January 31, 2024
Drug prices
Pharmaceutical industry close to deal with UK on drug pricing, says Novartis
...The results focus on the remaining business, focused on innovative drugs, after Novartis spun out its generics division Sandoz this month....
October 24, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Novartis AG
Novartis plans $15bn buyback after failing to find deals
...As part of that plan, the company is spinning off its generics drugs division Sandoz....
July 18, 2023
Live news updates from July 18: BBC hires Deloitte to review procedures, Morgan Stanley profits fall
Novartis launches $15bn share buyback as strong sales boost outlook
...Novartis also said its board of directors has “unanimously” endorsed the total spin-off of generics division Sandoz, first announced last year....
July 18, 2023
Executive Pay
UK boards and investors push for higher CEO pay to bridge gap with US
...One senior UK investment banker said there was “a bit of a brain drain” away from listed corporations towards private equity-backed businesses....
March 2, 2024
Novartis AG
Novartis chief criticises EU move to control pharma licensing in emergencies
...Narasimhan is refocusing Novartis on pharmaceuticals and has disposed of the company’s consumer health and eyecare divisions....
April 25, 2023
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
News in-depthCorporation tax
Europe’s thriving businesses face mounting windfall tax hit
...Hungary has imposed levies on all financial institutions, including insurance companies, as well as pharmaceutical groups....
August 13, 2023
Novartis AG
Novartis to spin off generic drugs unit Sandoz
...Spinning off its Sandoz division would create the largest generic drugs company in Europe by sales, Novartis said on Thursday, as it set out one of its most significant moves to focus on faster-growing and...
August 25, 2022
News in-depthAstraZeneca PLC
AstraZeneca defies geopolitics to bet on China
...“Leon is open to everything,” said Bruce Liu, who leads the life sciences division for China at consultancy Simon-Kucher & Partners. “He has been very innovative.”...
June 4, 2023
Transcript
Best Of: Inside Johnson & Johnson’s bankruptcy two-step
...Jamie Smyth In Johnson & Johnson’s case, the company’s consumer products subsidiary that had been selling the talc baby powder and the existing pharmaceutical and medical device divisions keep their assets...
May 31, 2023
FT Magazine
A controversial biotech and an unlikely anorexia treatment
...Psilocybin was first clinically manufactured in 1959 by Sandoz, now part of Novartis, but the company had never commercialised it....
March 2, 2023
Novartis AG
Novartis says all options open on Sandoz after private equity interest emerges
...Other pharmaceutical companies have also shown early interest in the unit, Narasimhan has told the FT....
February 2, 2022
Novartis AG
Private equity firms consider bids of $25bn for Novartis generics unit
...Several private equity firms are considering bids of up to $25bn for Sandoz, the generic drugs business belonging to pharmaceutical company Novartis, according to multiple people with knowledge of the situation...
February 1, 2022
Rana Foroohar
Letting the public decide is key to Big Tech regulation
...Industries like finance, pharmaceuticals and particularly technology are rife with examples....
February 6, 2023
Special ReportAsia-Pacific Innovative Lawyers
Practice of law: best practice in legal work
...Paul Hastings O: 6; L: 7; I: 7; Total: 20The firm advised South Korean pharmaceutical company SD Biosensor and South Korean private equity fund SJL Partners on the acquisition of US-listed pharmaceutical...
May 5, 2023
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
Novartis AG
Novartis shakes up structure to strengthen US business
...The pharmaceuticals division’s focus on speciality drugs now gives it a more similar profile to the oncology unit....
April 4, 2022
Novartis AG
Novartis launches strategic review of generics business Sandoz
...Swiss drugmaker Novartis has launched a strategic review of its generics business Sandoz, which might lead to the division being spun off....
October 26, 2021
LexNovartis AG
Novartis/Sandoz: selling generics would align Swiss giant with the times Premium content
...The generics division has long weighed on profitability. For 2020, the unit’s operating profit margins were 11 per cent — half those of the innovative medicines division....
October 26, 2021
Transcript
Inside Johnson & Johnson’s bankruptcy two-step
...Jamie Smyth In Johnson & Johnson’s case, the company’s consumer products subsidiary that had been selling the talc baby powder and the existing pharmaceutical and medical device divisions keep their assets...
June 15, 2022
Roche Holding AG
Novartis to sell its Roche stake worth $21bn
...Narasimhan has sought to refocus Novartis since taking the helm in 2018, spinning off its eye-care unit and last week unveiling a strategic review of its generics division Sandoz, which could include a sale...
November 4, 2021
Due Diligence
KPMG partners who were told to ‘stop moaning’ last year receive a pay bump Premium content
...One thing to watch: Several private equity firms including Blackstone, Carlyle and EQT are considering bids of up to $25bn for Sandoz, the generic drugs business belonging to pharmaceutical company Novartis...
February 2, 2022
Investor activism
Activist investors descend on ‘bargain basement’ UK companies
...GSK has been targeted by Elliott Advisors, which is pushing to overhaul the pharmaceuticals group’s leadership....
February 2, 2022
Novartis AG
Novartis warns of pandemic delay in cancer diagnoses
...This article has been updated to reflect that antibiotic sales in the Sandoz division were hit by a weak cough and cold season....
April 27, 2021
News in-depthCorporation tax
Multinationals shrug off G7 tax assault
...To prevent Amazon’s profitable cloud division from being sheltered under its low-margin ecommerce business, for instance, the OECD is exploring a way to tax the division separately....
June 11, 2021
FT Wealth
Alpine attraction: Switzerland is a magnet for family offices
...These include the vehicle of the Sandoz family — hoteliers and founders of the eponymous pharmaceuticals company that is now part of Novartis — and Loreda, which manages the wealth of Hansjörg Wyss, a prominent...
October 19, 2021

Previous pagePage 1 of 8Next page